-
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
drugs
June 14, 2019
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis.
-
'Double-Edged Sword': Lung Cancer Radiation Rx May Raise Heart Attack Risk
drugs
June 14, 2019
Lung Cancer Radiation Rx May Raise Heart Attack Risk.
-
Your Drinking Water May Harbor Cancer-Causing Nitrate: Study
drugs
June 13, 2019
Your Drinking Water May Harbor Cancer-Causing Nitrate.
-
Chemoradiation Does Not Up Survival in Endometrial Cancer
drugs
June 13, 2019
Chemoradiation Does Not Up Survival in Endometrial Cancer.
-
Cancer Survivors Predicted to Top 22 Million by 2030
drugs
June 12, 2019
Cancer Survivors Predicted to Top 22 Million by 2030.
-
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
drugs
June 11, 2019
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer.
-
ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer
drugs
June 06, 2019
Enzalutamide Beneficial in Metastatic Prostate Cancer.
-
Few Prostate Cancer Patients Are Getting Checkups They Need
drugs
June 06, 2019
Few Prostate Cancer Patients Are Getting Checkups They Need.
-
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer
drugs
June 06, 2019
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer.
-
Lynparza reduces PFS in germline BRCA-mutated pancreatic cancer
pharmaceutical-technology
June 05, 2019
AstraZeneca and Merck have announced that Lynparza (olaparib) demonstrated significant improvement in progression-free survival (PFS), compared to placebo, in germline BRCA-mutated metastatic .adenocarcinoma of the pancreas.